Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term

Quest Diagnostics (DGX) is highlighted as a compelling long-term value opportunity, despite its Zacks #3 (Hold) Rank. The company boasts strong fundamental indicators, including a Zacks VGM Score of 'A' and a Value Style Score of 'B', underpinned by an attractive forward P/E of 18.35. Analyst sentiment is positive, with nine analysts revising fiscal 2025 earnings estimates upwards in the last 60 days, raising the Zacks Consensus Estimate to $9.74 per share, alongside a consistent average earnings surprise of +2.1%.

Analysis

Quest Diagnostics (DGX) presents a mixed but compelling profile for value-oriented investors. Despite a neutral Zacks #3 (Hold) rank, the company exhibits strong underlying fundamentals, highlighted by a top-tier VGM Score of 'A' and a favorable Value Style Score of 'B'. The bullish case is supported by its valuation, with a forward P/E ratio of 18.35, which is presented as attractive. Furthermore, forward-looking sentiment from the analyst community is positive; nine analysts have revised their fiscal 2025 earnings estimates upward within the last 60 days. This has lifted the Zacks Consensus Estimate by $0.04 to $9.74 per share. The company's operational reliability is underscored by a consistent history of positive performance, boasting an average earnings surprise of +2.1%. This combination of attractive valuation metrics and positive earnings estimate revisions suggests potential upside that may not be fully reflected in its current 'Hold' rating.

Key Decisions for Investors

• Value-oriented investors should consider the dissonance between the neutral 'Hold' rating and the strong 'A' grade VGM score and positive analyst revisions, as this may signal an undervalued opportunity.
• Monitor upcoming earnings reports and analyst commentary closely, as the positive trend in fiscal 2025 earnings estimates could act as a catalyst for a future rating upgrade and share price appreciation.
• Given the attractive forward P/E of 18.35 and a consistent record of earnings beats, establishing a long-term position could be prudent, treating the current 'Hold' rating as a point of caution rather than a prohibitive signal.